Fulltext

World addiction medicine reports: formation of the International Society of Addiction Medicine Global Expert Network (ISAM-GEN) and its global surveys

Ekhtiari H 1 , Khojasteh Zonoozi A 2 , Rafei P 3 , Abolghasemi FS 2 , Pemstein D 4 , Abdelgawad T 5 Show all authors , Achab S 6 , Ghafri HA 7 , Al'Absi M 1 , Bisch M 8 , Conti AA 9 , Ambekar A 10 , Arunogiri S 11 , Bhad R 10 , Bilici R 12 , Brady K 13 , Bunt G 14 , Busse A 15 , Butner JL 16 , Danesh A 17 , El-Khoury J 18 , Omari FE 19 , Jokūbonis D 20 , de Jong C 21 , Dom G 22 , Ebrahimi M 2 , Fathi Jouzdani A 2 , Ferri M 23 , Galea-Singer S 24 , Parker DG 25 , Higuchi S 26 , Kathiresan P 27 , Khelifa E 28 , Kouimtsidis C 29 , Krupitsky EM 30 , Long J 31 , Maremmani I 32 , McGovern G 33 , Mohaddes Ardabili H 2 , Rahimi-Movaghar A 2 , Rataemane ST 34 , Sangchooli A 35 , Sibeko G 36 , Vella AM 37 , Vista SBD 38 , Zare-Bidoky M 2 , Zhao M 39 , Javed A 40 , Potenza MN 41 , Baldacchino AM 24

Affiliations 

  • 1 Department of Psychiatry, University of Minnesota, Minneapolis, MN, United States
  • 2 Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
  • 3 Trinity College Institute of Neuroscience (TCIN), Trinity College Dublin, Dublin, Ireland
  • 4 Political Science and Public Policy & Challey Institute, North Dakota State University, Fargo, ND, United States
  • 5 Faculty of Medicine, Cairo University, Cairo, Egypt
  • 6 Faculty of Medicine, Sociological and Psychological Research Unit, Department of Psychiatry, University of Geneva, Geneva, Switzerland
  • 7 National Rehabilitation Center, Abu Dhabi, United Arab Emirates
  • 8 Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France
  • 9 Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
  • 10 National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India
  • 11 Monash Addiction Research Centre, Eastern Health Clinical School, Melbourne, VIC, Australia
  • 12 Faculty of Medicine, Department of Psychology, Istanbul Ticaret University, Istanbul, Türkiye
  • 13 Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States
  • 14 School of Medicine, New York University, New York City, NY, United States
  • 15 Prevention, Treatment and Rehabilitation Section, United Nations Office on Drugs and Crime (UNODC), Vienna, Austria
  • 16 Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States
  • 17 Division of Prevention Science, University of California, San Francisco, San Francisco, CA, United States
  • 18 Lebanese Psychiatric Society, Beirut, Lebanon
  • 19 Faculty of Medicine, University Mohammed Vth of Rabat, Rabat, Morocco
  • 20 Republican Center for Addictive Disorders, Lithuanian University of Health Sciences, Kaunas, Lithuania
  • 21 Behavioral Science Institute, Radboud University, Nijmegen, Netherlands
  • 22 Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium
  • 23 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal
  • 24 DigitAS Project, Population and Behavioural Science, School of Medicine, University of St Andrews, St Andrews, United Kingdom
  • 25 School of Public Health, National University of Cordoba, Cordoba, Argentina
  • 26 National Hospital Organization Kurihama Medical and Addiction Center, Yokosuka, Japan
  • 27 Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, India
  • 28 Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia
  • 29 National Office for Addressing Drugs, Athens, Greece
  • 30 Department of Addictions, Bekhterev National Medical Research Center for Psychiatry and Neurology, St. Petersburg, Russia
  • 31 Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 32 Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy
  • 33 Irish Chapter of International Society of Addiction Medicine (IRE-ISAM), Dublin, Ireland
  • 34 Department of Psychiatry, University of Limpopo, Polokwane, South Africa
  • 35 Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, VIC, Australia
  • 36 Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa
  • 37 Foundation for Social Welfare Services (FSWS), Sedqa, Santa Venera, Malta
  • 38 Department of Psychiatry and Behavioral Medicine, College of Medicine and Philippines General Hospital, University of the Philippines Manila, Manila, Philippines
  • 39 Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China
  • 40 Pakistan Psychiatric Research Centre, Fountain House, Lahore, Pakistan
  • 41 Department of Psychiatry and Child Center, Yale School of Medicine, New Haven, CT, United States
Front Psychiatry, 2024;15:1230318.
PMID: 38528974 DOI: 10.3389/fpsyt.2024.1230318

Abstract

Addiction medicine is a dynamic field that encompasses clinical practice and research in the context of societal, economic, and cultural factors at the local, national, regional, and global levels. This field has evolved profoundly during the past decades in terms of scopes and activities with the contribution of addiction medicine scientists and professionals globally. The dynamic nature of drug addiction at the global level has resulted in a crucial need for developing an international collaborative network of addiction societies, treatment programs and experts to monitor emerging national, regional, and global concerns. This protocol paper presents methodological details of running longitudinal surveys at national, regional, and global levels through the Global Expert Network of the International Society of Addiction Medicine (ISAM-GEN). The initial formation of the network with a recruitment phase and a round of snowball sampling provided 354 experts from 78 countries across the globe. In addition, 43 national/regional addiction societies/associations are also included in the database. The surveys will be developed by global experts in addiction medicine on treatment services, service coverage, co-occurring disorders, treatment standards and barriers, emerging addictions and/or dynamic changes in treatment needs worldwide. Survey participants in categories of (1) addiction societies/associations, (2) addiction treatment programs, (3) addiction experts/clinicians and (4) related stakeholders will respond to these global longitudinal surveys. The results will be analyzed and cross-examined with available data and peer-reviewed for publication.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications